Tag: Sarah Cannon

Celebrate World Cancer Day

Today is World Cancer Day – a day to celebrate and honor the strength and courage that survivors around the world show every day in their fight against cancer, and to highlight the progress being made to advance treatments for patients. World Cancer Day brings together caregivers, doctors, researchers, family, friends and communities to show the power of working together – as shown in the theme “We Can. I Can.” Sarah Cannon, the Cancer Institute of HCA, put together a video montage of their care teams and colleagues across their global network to encourage patients fighting in their journey and… Read more.

How to Protect Yourself from Cervical Cancer

You may know Erin Andrews as an NFL sideline reporter, co-host on the television show “Dancing with the Stars” or as the victim of a stalking incident and subsequent defendant in a highly publicized trial.  And now, the sportscaster/television personality has gone public with a private battle against cervical cancer. Through her announcement, Andrews, who underwent a successful surgery for the condition, has helped raise awareness of cervical cancer and the importance of routine screenings. Drs. Cecelia Boardman and Tyler Ford of HCA Virginia Physicians share more details about how women can protect themselves from human papillomavirus (HPV), a condition… Read more.

HCA Dedicates New Building in Nashville

HCA co-founder Dr. Tommy Frist, Jr., Chairman and CEO Milton Johnson, First Lady Crissy Haslam and Nashville Mayor Megan Barry last Friday celebrated our nearly 50-year history in Tennessee with the dedication of 1100 Charlotte at Capitol View – the company’s new 17-story building in Nashville. The 1100 Charlotte building serves as headquarters for our subsidiaries HealthTrust, Sarah Cannon and Parallon, and is the anchor tenant for a new development called Capitol View. Redefining Nashville’s skyline, the $200 million investment is bringing close to 2,000 jobs to the area and will serve as a catalyst for growth in the neighborhood… Read more.

Sarah Cannon Talks Genetic Testing, Breast Cancer Surgical Choices

When Angelina Jolie opted to undergo a double mastectomy and then publicize it in 2013 after genetic testing revealed she carried the BRCA1 gene, it sparked a lot of conversations about genetic testing and ultimately led to an increase in breast removal surgeries. With 1 in 8 women developing breast cancer, many women and their families ask questions such as… What causes breast cancer? How much do genetics impact the risk for developing breast cancer? The cancer experts at Sarah Cannon, our cancer institute, are here to answer questions for you or a loved one. Learn about the role of genetics in… Read more.

Sarah Cannon, HCA Midwest Health Announce Cancer Research Collaboration

Last week, Sarah Cannon, our global cancer institute, and HCA Midwest Health, Kansas City’s largest healthcare network, announced that they expanded their cancer collaboration through clinical research. By joining a global research network, HCA Midwest Health is now offering greater access to clinical trials for those facing cancer in the Kansas City region. “Clinical trials are an integral part of advancing the standard of cancer care, as today’s trials are tomorrow’s cutting-edge treatments,” said Dr. Howard A. “Skip” Burris, III, president of clinical operations and chief medical officer at Sarah Cannon. “By expanding our collaboration, we can provide patients in… Read more.

Dr. Erika Hamilton Appears on CNN to Discuss American Cancer Society’s New Breast Cancer Screening Guidelines

Dr. Erika Hamilton, Associate Director, Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute – the research arm of our global cancer enterprise, Sarah Cannon – was featured on CNN today regarding the American Cancer Society’s new screening guidelines just released. New screening guidelines state that women should begin getting mammograms at age 45 instead of 40 and all women can forego routine manual breast checks by physicians. One of the reasons surrounding these changes are that mammograms have a fairly high false-positive rate and the chance of false-positives increase under age 45 as women in this… Read more.

Sarah Cannon Expert Discusses Early Stage Breast Cancer on Fox News

Dr. Erika Hamilton, Associate Director of the Breast Cancer and Gynecologic Cancer Research Program at the Sarah Cannon Research Institute – the research arm of our global cancer enterprise, Sarah Cannon – was featured on Fox News in August to discuss a study released on DCIS, early stage breast cancer.  DCIS (Ductal Carcinoma In Situ), commonly referred to as “stage zero breast cancer”, is an abnormal collection of cancer cells inside the milk ducts of the breasts. According to the American Cancer Society, approximately 60,000 women are diagnosed with DCIS each year. That’s one out of five new breast cancer… Read more.

What to do when it’s Breast Cancer

Cancer does not discriminate. Young or old, rich or poor, healthy or inactive, more than one million people in the U.S. are diagnosed with cancer each year. For women, breast cancer is the second most commonly diagnosed cancer (behind skin cancer) in the nation. In fact, one out of eight American women will develop breast cancer over the course of their lifetime. That’s why the conversation on breast cancer is front and center every October – Breast Cancer Awareness Month. Understanding breast cancer is important. The annual campaign to increase awareness, raise funds and educate people on detection, diagnosis and… Read more.

Sarah Cannon Blood Cancer Network’s Tulane Medical Center Receives International Accreditation

Did you know every three minutes someone is diagnosed with blood cancer? And that it takes a team approach to more effectively treat blood cancer? That is why Sarah Cannon, HCA’s global cancer enterprise, formed the Sarah Cannon Blood Cancer Network that brings together leading providers of blood cancer care for patients seeking treatment. HCA’s Tulane Medical Center, a member of the Blood Cancer Network, recently announced that it is now internationally recognized by the Foundation for the Accreditation of Cellular Therapy (FACT), the threshold for excellence in blood and marrow transplants. Founded in 1994, Tulane Medical Center’s Bone Marrow… Read more.

Sarah Cannon Expert Comments on Former President Carter’s Cancer Announcement

Dr. Johanna Bendell, Director of the GI Cancer Research Program and Associate Director of the Drug Development Program at Sarah Cannon Research Institute – the research arm of HCA’s global cancer enterprise Sarah Cannon – was featured on CNN, Fox News, and MSNBC Thursday morning to provide insight on former U.S. President Jimmy Carter’s recent cancer announcement. Dr. Bendell discusses the brief statement released by the former president and the positive impact the president’s active lifestyle may have on his treatment options. Sarah Cannon provides state-of-the-art cancer care and access to clinical trials close to home for hundreds of thousands… Read more.

Join our email newsletter

Recent HCA Tweets

HCA Categories